文献速递妇科

阴道网片是否会刺激自身免疫性疾病的发生

Is vaginal mesh a stimulus of autoimmune disease?
PubMed 文献 · Am J Obstet Gynecol · 2016-12-26

本研究利用纽约州住院与门诊手术数据开展回顾性队列研究,纳入2008年1月至2009年12月因盆腔器官脱垂接受阴道网片植入手术的成年女性2102例,并与结肠镜筛查队列37298例及良性妇科疾病阴道子宫切除队列7338例按人口学、合并症和手术日期个体匹配。匹配后分析显示,网片手术在任何评估时段(1年、2年、3年及至2014年12月最长6年随访)均与自身免疫性疾病风险升高无关。

要点

  • 阴道网片植入手术与自身免疫性疾病发生风险升高无关。
  • 匹配后1年、2年、3年及最长6年随访各时段均未见风险增加。
  • 作者结论认为这些数据反驳了网片导致系统性疾病的说法。

核心结论

  • 基于阴道网片的盆腔器官脱垂手术与系统性/自身免疫性疾病的发生无关。
  • 作者认为这些数据反驳了网片作为系统性疾病病因的说法。

研究设计与样本

  • 回顾性队列研究,利用纽约州卫生部全州规划与研究合作系统数据。
  • 网片队列为2008年1月至2009年12月在纽约州住院和门诊手术机构因盆腔器官脱垂接受阴道网片植入手术的成年女性,共2102例。
  • 对照队列包括结肠镜筛查队列37298例和因良性妇科疾病行阴道子宫切除(未行盆腔器官脱垂修复或吊带)队列7338例。
  • 网片队列患者按人口学特征、合并症和手术日期与对照队列进行个体匹配。

主要发现

  • 匹配前及匹配后,在1年、2年、3年和整个随访期(至2014年12月,最长6年)评估系统性/自身免疫性疾病的发生。
  • 按人口学特征、合并症和手术时间匹配后,网片手术在任何评估时段均与自身免疫性疾病风险升高无关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polypropylene mesh has been used as a means of reinforcing weak tissues in women with pelvic organ prolapse and stress urinary incontinence. OBJECTIVE: We sought to investigate a potential link between the development of systemic/autoimmune disorders and synthetic polypropylene mesh repairs. STUDY DESIGN: New York State Department of Health Statewide Planning and Research Cooperative System data were utilized to conduct this retrospective cohort study. Adult women undergoing surgery for pelvic organ prolapse with vaginally implanted mesh from January 2008 through December 2009 in inpatient and ambulatory surgery settings in New York State were identified. Two separate control cohorts were created to compare outcomes, including a screening colonoscopy cohort and a vaginal hysterectomy cohort for benign gynecologic conditions (without pelvic organ prolapse repair or sling). Patients in the mesh cohort were individually matched to the control cohorts based on demographics, comorbidities, and procedure date. The development of systemic/autoimmune disease was determined before and after matching for 1-year, 2-year, 3-year, and entire follow-up (up to 6 years until December 2014) and differences between groups were evaluated. RESULTS: A total of 2102 patients underwent mesh-based pelvic organ prolapse surgery from January 2008 through December 2009. In the control cohorts, 37,298 patients underwent colonoscopy and 7338 underwent vaginal hysterectomy. When patients were matched based on demographics, comorbidities, and procedure time, mesh-based surgery was not associated with an increased risk of developing autoimmune disease at any of the evaluated time periods. CONCLUSION: Mesh-based vaginal surgery was not associated with the development of systemic/autoimmune diseases. These data refute claims against mesh as a cause of systemic disease.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Chughtai B, Sedrakyan A, Mao J, et al. Is vaginal mesh a stimulus of autoimmune disease? Am J Obstet Gynecol. 2016. PMID: 28034649. doi:10.1016/j.ajog.2016.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。